Skip to content

a Phase III Trial of Safety and Efficacy of Premedication With Dexmedetomidine and Midazolam in Pediatric Patients

A Partially Double-Blinded, Randomized, Controlled, Placebo-Controlled Study, a Phase III Trial of Safety and Efficacy of Premedication With Dexmedetomidine and Midazolam in Pediatric Patients

Status
UNKNOWN
Phases
Phase 3
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04356638
Enrollment
80
Registered
2020-04-22
Start date
2021-10-17
Completion date
2023-12-30
Last updated
2023-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Anxiety State, Perioperative/Postoperative Complications

Brief summary

This research study to evaluate the relative efficacy of Dexmedetomidine, Midazolam, and compare them to the current KFSH&RC standard of care. Compare the safety and the frequency of adverse effects of treatment arms.

Interventions

DRUGMidazolam

Oral Midazolam and intranasal placebo

DRUGDexmedetomidine

Intranasal Dexmedetomidine and oral placebo

OTHERPlacebo

Placebo orally and intranasally

Sponsors

King Faisal Specialist Hospital & Research Center
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE
Masking
DOUBLE (Subject, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
12 Months to 12 Years
Healthy volunteers
No

Inclusion criteria

* All pediatric outpatients coming for MRI investigations requiring general anesthesia at King Faisal Specialist Hospital & Research Center (KFSH&RC) age 1-12 years

Exclusion criteria

* Weight ≥ 40 kilograms * Allergies to the study drug * Refused to take the study drug * Severe learning disability * Patient on Digoxin medication * Patient on beta-blocker medication * Cardiac disease with abnormal conduction system * Nasal anatomical abnormality

Design outcomes

Primary

MeasureTime frameDescription
Anxiety Level30 MinutesComparison of the level of anxiety as measured by The Modified Yale Preoperative Anxiety Scale - Short Form (mYPAS-SF) at the time when the child checks in at the front desk (say mYPAS-SF1), with when the attempt will be made to insert an IV line (say mYPAS-SF2). This scale is a score ranging from four (little anxiety) to twenty two (much anxiety).
Safety - Hemodynamic stability30 MinutesThe systolic and diastolic blood pressures will be measured when the subject enters the recovery room, and then each ten minutes until the subject goes into the MRI suite and general anesthesia is induced.
Safety - Respiratory function30 MinutesThe respiratory rate will be measured when the subject enters the recovery room, and then each ten minutes until the subject goes into the MRI suite and general anesthesia is induced.
Oxygen saturation30 MinutesThe SpO2 will be measured when the subject enters the recovery room, and then each ten minutes until the subject goes into the MRI suite and general anesthesia is induced.

Secondary

MeasureTime frameDescription
Visual Analog Scale for child anxiety10 MinutesThe VAS will be measured when the subject enters the recovery room and when IV cannulation is performed
Post Hospitalization Behavior Questionnaire for Ambulatory SurgeryDay 2 post procedureA two day post assessment will be completed by interviewing the parents about changes in behavior derived from the questionnaire
IV cannulation procedure completion and number of attempts - yes or no10 MinutesThis will be measured when the IV cannulation procedure is successful or not
Likert scale assessment of how cooperative/easy to handle the child10 MinutesThis will be measured when the IV cannulation is completed
Assessment of the Pediatric Anesthesia Emergence Delirium (PAED-scale) for the subjects60 MinutesThis measurement will assess the emergence delirium of the participants when they have completed the MRI under general anesthesia - every 10 minutes until discharge from recovery room

Countries

Saudi Arabia

Contacts

Primary ContactLars Engborg, MD
lengborg@kfshrc.edu.sa+966555327987
Backup ContactDean Turina, MD BSc
dturina8@kfshrc.edu.sa+966500343041

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026